Gallup has come out with new survey data suggesting that health insurers’ efforts to talk about the effects of higher prescription drug prices on health care costs may be paying off.
See also: Health insurers may be outcharming drug makers
The percentage of Americans the organization surveyed in August who said they had a positive opinion of the pharmaceutical industry dropped to 35 percent, from 40 percent, and the percentage with a negative view increased to 43 percent, from 36 percent.
Jim Norman, a Gallup analyst, computed a net view index by subtracting from the negative view level from the positive view level.
The negative 8 percent net view is down from a positive 4 percent net view in 2014, but up from 10 percent in 2013.